Astrid Brull

567 total citations
22 papers, 398 citations indexed

About

Astrid Brull is a scholar working on Rheumatology, Molecular Biology and Neurology. According to data from OpenAlex, Astrid Brull has authored 22 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 12 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Astrid Brull's work include Glycogen Storage Diseases and Myoclonus (14 papers), Muscle Physiology and Disorders (7 papers) and Neurological disorders and treatments (5 papers). Astrid Brull is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (14 papers), Muscle Physiology and Disorders (7 papers) and Neurological disorders and treatments (5 papers). Astrid Brull collaborates with scholars based in Spain, France and Denmark. Astrid Brull's co-authors include Tomàs Pinós, Alejandro Lucía, Noemí de Luna, Antoni L. Andreu, Gisela Nogales‐Gadea, Alfredo Santalla, Miguel A. Martı́n, Joaquı́n Arenas, Gisèle Bonne and A. Bertrand and has published in prestigious journals such as Brain, Hepatology and The Journal of Physiology.

In The Last Decade

Astrid Brull

21 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Brull Spain 13 216 198 109 83 71 22 398
Carlos Cervera Spain 13 291 1.3× 156 0.8× 80 0.7× 89 1.1× 61 0.9× 20 465
Pascal Laforêt France 9 178 0.8× 118 0.6× 48 0.4× 41 0.5× 133 1.9× 18 367
Stayko Sarafov Bulgaria 9 215 1.0× 45 0.2× 68 0.6× 68 0.8× 41 0.6× 20 297
Serena Pagliarani Italy 11 152 0.7× 131 0.7× 78 0.7× 38 0.5× 63 0.9× 26 294
Ulf Drugge Sweden 11 328 1.5× 69 0.3× 96 0.9× 118 1.4× 57 0.8× 26 501
Charalampos Karadimas Greece 14 473 2.2× 55 0.3× 135 1.2× 32 0.4× 41 0.6× 17 627
S. Gambelli Italy 11 191 0.9× 39 0.2× 30 0.3× 80 1.0× 21 0.3× 20 347
Annabel K. Wang United States 6 127 0.6× 42 0.2× 24 0.2× 105 1.3× 100 1.4× 10 280
M. Osborn United Kingdom 9 291 1.3× 71 0.4× 61 0.6× 182 2.2× 18 0.3× 13 495
Martin A. Haagmans Netherlands 7 157 0.7× 23 0.1× 43 0.4× 51 0.6× 41 0.6× 11 301

Countries citing papers authored by Astrid Brull

Since Specialization
Citations

This map shows the geographic impact of Astrid Brull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Brull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Brull more than expected).

Fields of papers citing papers by Astrid Brull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Brull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Brull. The network helps show where Astrid Brull may publish in the future.

Co-authorship network of co-authors of Astrid Brull

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Brull. A scholar is included among the top collaborators of Astrid Brull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Brull. Astrid Brull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brull, Astrid, et al.. (2024). Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy. Molecular Therapy — Nucleic Acids. 35(2). 102178–102178. 8 indexed citations
2.
Bolduc, Véronique, et al.. (2024). Allele-specific CRISPR-Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy. Molecular Therapy — Nucleic Acids. 35(3). 102269–102269. 3 indexed citations
3.
Okubo, Mariko, Astrid Brull, Maud Beuvin, et al.. (2023). O03 In vivo gene therapy for striated muscle laminopathy. Neuromuscular Disorders. 33. S67–S67.
4.
Brull, Astrid, Gisela Nogales‐Gadea, Antoni L. Andreu, et al.. (2021). Preclinical Research in McArdle Disease: A Review of Research Models and Therapeutic Strategies. Genes. 13(1). 74–74. 5 indexed citations
5.
Owens, Daniel J., Sophie Moog, Arnaud Ferry, et al.. (2020). Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth. International Journal of Molecular Sciences. 22(1). 306–306. 21 indexed citations
6.
7.
Luna, Noemí de, Astrid Brull, Miguel A. Martı́n, et al.. (2019). Absence of p.R50X Pygm read-through in McArdle disease cellular models. Disease Models & Mechanisms. 13(1). 10 indexed citations
8.
Brull, Astrid, Alejandro Lucía, Miguel A. Martı́n, et al.. (2019). Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model. Scientific Reports. 9(1). 5116–5116. 12 indexed citations
9.
McNamara, Elyshia, Rhonda L. Taylor, Joshua S. Clayton, et al.. (2019). Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease. Human Molecular Genetics. 29(1). 20–30. 12 indexed citations
10.
Brull, Astrid, et al.. (2018). The Pathogenesis and Therapies of Striated Muscle Laminopathies. Frontiers in Physiology. 9. 1533–1533. 24 indexed citations
11.
Taylor, Rhonda L., Mark R. Davis, Emma L. Turner, et al.. (2018). Clinical utility gene card for McArdle disease. European Journal of Human Genetics. 26(5). 758–764. 3 indexed citations
12.
Azibani, Fériel, Astrid Brull, Ludovic Arandel, et al.. (2017). Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy. Molecular Therapy — Nucleic Acids. 10. 376–386. 32 indexed citations
13.
Pinós, Tomàs, et al.. (2017). Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse. Molecular Genetics and Metabolism. 123(1). 21–27. 8 indexed citations
14.
Krag, Thomas, et al.. (2016). Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease. Journal of Neuropathology & Experimental Neurology. 75(5). 441–454. 25 indexed citations
15.
Brull, Astrid, Noemí de Luna, Albert Blanco‐Grau, et al.. (2015). Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model. The Journal of Physiology. 593(12). 2693–2706. 16 indexed citations
16.
Nogales‐Gadea, Gisela, Astrid Brull, Alfredo Santalla, et al.. (2015). McArdle Disease: Update of Reported Mutations and Polymorphisms in thePYGMGene. Human Mutation. 36(7). 669–678. 51 indexed citations
17.
Luna, Noemí de, Astrid Brull, Alejandro Lucía, et al.. (2015). Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culturein vitro. Disease Models & Mechanisms. 8(5). 467–472. 19 indexed citations
18.
Santalla, Alfredo, Gisela Nogales‐Gadea, Niels Ørtenblad, et al.. (2014). McArdle Disease: A Unique Study Model in Sports Medicine. Sports Medicine. 44(11). 1531–1544. 38 indexed citations
19.
Coll, Mar, Sarai Rodríguez, Imma Raurell, et al.. (2012). Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats. Hepatology. 56(5). 1849–1860. 10 indexed citations
20.
Nogales‐Gadea, Gisela, Tomàs Pinós, Alejandro Lucía, et al.. (2012). Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain. 135(7). 2048–2057. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Cervera Breakdown of academic impact, for papers by Pascal Laforêt Breakdown of academic impact, for papers by Stayko Sarafov Breakdown of academic impact, for papers by Serena Pagliarani Breakdown of academic impact, for papers by Ulf Drugge Breakdown of academic impact, for papers by Charalampos Karadimas Breakdown of academic impact, for papers by S. Gambelli Breakdown of academic impact, for papers by Annabel K. Wang Breakdown of academic impact, for papers by M. Osborn Breakdown of academic impact, for papers by Martin A. Haagmans
Rankless by CCL
2026